The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease.
Diabetes Obes Metab
; 25(9): 2765-2769, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37246798
Full text:
1
Database:
MEDLINE
Main subject:
Coronary Artery Disease
/
Diabetes Mellitus, Type 2
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2023
Type:
Article
Affiliation country:
Canada